Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure-Reference-Cited by-同舟云学术

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

Published:2010-08 Issue:8 Volume:12 Page:826-832
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Shah Ravi V.¹,Chen-Tournoux Annabel A.¹,Picard Michael H.¹,van Kimmenade Roland R. J.²,Januzzi James L.¹

Affiliation:

1. Cardiology Division, Department of Medicine; Massachusetts General Hospital, Harvard Medical School; 32 Fruit Street, Yawkey 5984 Boston MA 02114 USA

2. Department of Cardiology; University Hospital Maastricht; Maastricht The Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study;Bleumink;Eur Heart J,2004

2. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients;Januzzi;Eur Heart J,2006

3. Cardiac troponin and outcome in acute heart failure;Peacock;N Engl J Med,2008

4. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study;Januzzi;J Am Coll Cardiol,2007

5. Biomarkers in heart failure;Braunwald;N Engl J Med,2008

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of suPAR, ST2, and galectin-3 with eGFR decline and mortality in patients with advanced heart failure with reduced ejection fraction;Journal of Investigative Medicine;2024-05-22

2. Galectin‐3 levels and long‐term all‐cause mortality and hospitalization in heart failure patients: a meta‐analysis;ESC Heart Failure;2024-05-03

3. Frailty and Metabolic Vulnerability in Heart Failure: A Community Cohort Study;Journal of the American Heart Association;2024-04-16

4. Galectin‐3, Metabolic Risk, and Incident Heart Failure: The ARIC Study;Journal of the American Heart Association;2024-03-19

5. Cardiomyopathy in cirrhosis: From pathophysiology to clinical care;JHEP Reports;2024-01